Back to AANN Webinar: Multiple Sclerosis Disease Modifying Treatment (DMT) Update and Recommendations for Patients in a Sars-CoV-2 Environment
AANN Webinar: Multiple Sclerosis Disease Modifying Treatment (DMT) Update and Recommendations for Patients in a Sars-CoV-2 Environment

AANN Webinar: Multiple Sclerosis Disease Modifying Treatment (DMT) Update and Recommendations for Patients in a Sars-CoV-2 Environment

Watch the recording of this webinar presented by Heidi Maloni, PhD ANP-BC CNRN MSCN.

Participants can receive 1 CE contact hour and 0.75 pharmacology credits for viewing the recording and completing the evaluation.

Learning Outcomes:
1. Define MS and commonly used disease modifying treatments
2. Identify recently approved MS disease modifying treatments
3. Describe coronavirus risk for people with MS and recommendations for DMT use

Product Details

Credit for the recording will expire on April 5, 2023.

AANN is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

The American Association of Neuroscience Nurses is accredited as a provider of continuing education by the California Board of Registered Nursing (CEP:13331)




  • List Price: Free
Back to Product Detail

Product Reviews

There are not any reviews for this product.

0